Solventum Q3 organic sales +2.7%; raises FY adj. EPS guidance to $5.98-$6.08

Solventum Corp

2025-Q3 EPS reported $8.53 revenue$6,327,000,000

Q3 reported sales $2.1B (+0.7% YoY); organic sales +2.7% driven by Dental Solutions and HIS.
GAAP diluted EPS $7.22 (includes large non-recurring gains); adjusted diluted EPS $1.50, down 8.5% YoY.
Adjusted operating margin 20.6% down 220bps due to tariffs, public-company costs, growth investments.
Full-year adj. EPS guidance raised to $5.98-$6.08; organic sales growth at high end of +2-3%.
Announces 4-year 'Transform for the Future' initiative; operating cash flow $75M, FCF -$22M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.